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We are writing in response to the letter by Sloan
et al.1 regarding our review of ‘Kangaroo mother
care’.2 We are happy to see the ongoing interest in
this publication and thank these colleagues for their
letter. We fully agree that meta-analysis is frequently
used inappropriately, especially given the ease of use
of Revman (Review Manager (RevMan) [Computer
program]. Version 5.0. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2008).
The published paper was not such a ‘quick and easy’
meta-analysis, but developed through an extensive
process for over 18 months with data kindly provided
by investigators, review at meetings of the Child
Health Epidemiology Reference Group (CHERG) and
by United Nations colleagues, as well as by external
reviewers for the journal, including members of the
Cochrane Collaboration.
We would again like to make it clear that this
review is not intended to be a Cochrane review. As
stated in the paper and in the introductory papers to
the supplement, all the Lives Saved Tool (LiST) re-
views follow a standard methodology developed by
CHERG and WHO using GRADE criteria.3 The reviews
are designed to inform inputs to LiST, which is a
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software tool designed to encourage evidence-based
programme investment for mortality effect in a
given country. The goal of this exercise is not to du-
plicate the work of the Cochrane collaboration, but to
provide transparent estimates of the cause-specific
mortality effects of priority interventions that are
being scaled up in low- and middle-income countries.
That said, it should be noted that the LiST review
process identified limitations in previous Cochrane re-
views. For example, the Cochrane review
meta-analysis for Kangaroo mother care (KMC) com-
bined mortality outcomes at 12 months, 6 months
and pre-discharge.4 Any review is likely to have limi-
tations and the goal for us all is to minimize these.
Intervention definition for
RCT mortality meta-analysis
In the paper, we clearly defined, a priori, that for mor-
tality outcomes we were examining the intervention
of KMC commencing in the first week of life. Sloan
et al. suggest that studies were excluded based on re-
sults. As stated in the paper, mortality studies were
included or excluded based on explicit criteria—
recruitment of babies with birth weight 2000 g and
on their median day of initiating KMC (Figure 1 and
Table 1 in the original article2). We did not use terms
mentioned in her letter such as ‘early KMC’ and ‘trad-
itional KMC’, as these may mean different things to
different expert groups—we preferred a specific, re-
producible measure regarding median day of
initiation of KMC. We included studies in which the
median day of KMC initiation was 7 (Charpak,5 4
days; Suman,6 3.7 days; Worku,7 <1 day) and we
excluded those studies in which the median day of
KMC initiation was47 days (Sloan et al.,8 12.4 days;
Cattaneo et al.,9 10 days). We also excluded the more
recent Sloan study from Bangladesh10 since birth
weight was not measured for most neonates in the
study, and there were other limitations in implement-
ing this trial in a challenging setting in rural
Bangladesh as discussed in the paper and as noted
in Sloan et al.’s communication now. In the paper,
we reported a sensitivity analysis including the two
late initiation studies in the meta-analysis (Sloan
et al.8 and Cattaneo et al.9). The mortality result re-
mained significant {relative risk (RR) 0.64 [95% con-
fidence interval (CI) 0.42–0.96]}.2
The reason for excluding studies of KMC starting
after the first week of life is that the mortality
effect of any intervention starting after the first
week could not be compared with those starting in
the first week since 75% of neonatal deaths occur in
the first week. Sloan suggests that the distribution of
neonatal mortality by day is ‘extremely variable’.
However, the proportion of neonatal deaths that
occur in the first week is actually remarkably stable
in both Vital Registration11 and Household Survey
data12 (Figure 1). Even with data limitations such
as age heaping on Day 7 and misclassification of
Day 0, there is a predictable distribution.13 We even
considered a cut-off before the first week of life be-
cause 50% of deaths occur in the first 48 h, and
475% occur in the first week. However, we applied
a conservative and clear cut-off for median com-
mencement of KMC by day 7.
We do not accept that studies were selected based
on their results. They were selected on explicit, preset
criteria, which in this case related to the usual PICO
format of Patient, Intervention Comparison Outcome.
Outcome definition for RCT
mortality meta-analysis
Our review focused on ‘neonatal’ mortality, which dif-
fers from the earlier Cochrane review (Conde
Aguedelo 2003)4 in which the mortality meta-analysis
combined infant mortality,5 6-month mortality8 and
pre-discharge mortality.9 Both Charpak and Suman
kindly provided us with their unpublished neonatal
mortality data. The Worku trial7 was based on
pre-discharge neonatal mortality and we recognized
this as a limitation and discussed this in the text
and the detailed GRADE webtable marks down the
quality based on this and other limitations.
Although some post-discharge neonatal deaths may
have been missed, given the steep survival curve,
such deaths are likely to have been a small proportion
and given the expectation of fewer deaths in the KMC
Figure 1 Daily risk of death during first month of life
based on analysis of 47 DHS data sets (1995–2003) with
10 048 neonatal deaths. Deaths in first 24 h recorded as
occurring on Day 0, or possibly Day 1, depending on inter-
pretation of question and coding of response. Preference for
reporting certain days (7, 14, 21 and 30) is apparent.
Between 73 and 76% of neonatal deaths occur in the first
7 days after birth. Source: The Lancet.12
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group this loss to follow-up bias will be expected to
weaken the effect size and is conservative. In the
Suman trial,6 where cases were followed after dis-
charge, no further neonatal deaths were identified
post-discharge in control or intervention arms.
We do not agree with Sloan et al.’s point that it is
incorrect to undertake meta-analysis of trials for an
outcome (in this instance neonatal mortality) that
those trials were not individually powered to examine.
Indeed, we would argue that one of the most import-
ant uses of meta-analysis is precisely for such
situations.
Neither do we accept their argument that these stu-
dies are too heterogeneous to be combined. We fol-
lowed standard meta-analysis rules to examine for
heterogeneity using the I2 statistic as laid out in our
methods section under the subtitle ‘Analyses, and
summary measures’. For these three RCTs, the
I2¼ 0.0%, P¼ 0.539 and so a fixed effects meta-
analysis was appropriate. Mantel–Haenszel weights
were used to combine the studies. The weight given
to Worku simply reflects lower standard error in their
estimates, as shown by the narrower confidence inter-
val. This is the standard approach to weighting. No
special weighting was applied.
Mortality outcome observational
study meta-analysis
Sloan et al. state that a meta-analysis of observation
studies ‘is almost a contradiction in terms’ and should
not be done. Once again we emphasize that this
review is not a Cochrane review—our purpose is to
examine the data to inform implementation at scale.
As stated in the paper, the purpose was to examine
whether the effect estimate obtained from small,
RCTs measuring efficacy would be consistent with
the effect estimate obtained from larger, observational
studies with weaker designs. The paper explicitly al-
locates these observational studies a low level of evi-
dence. This meta-analysis is of relevance to
programmatic planners since the results suggest that
wide-scale, routine implementation of KMC is still
associated with considerable mortality reduction of
around 32% reduction in deaths for babies under
2000 gms.
Morbidity outcome RCT
meta-analysis
We agree that our paper should have had more de-
tailed discussion of the inputs for the morbidity
meta-analysis compared with the mortality analysis.
The reported morbidity outcomes in most of these
trials are beyond the neonatal period and morbidity,
notably infections in pre-term infants tends to peak
later than mortality. The paper presented a
meta-analysis with studies of both early and late ini-
tiation of KMC [RR 0.34 (95% CI 0.17–0.65)].2 We
should also have reported a meta-analysis
excluding the KMC studies with later initiation as
per the criteria set out for the mortality RCT
meta-analysis. The results of this analysis are not
very different in terms of the point estimate [RR
0.25 (95% CI 0.06–1.07)].
Weight cut-off of <2000 g
We state in the paper which of the studies included
had a weight cut-off of 2000 g. A lower cut-off will
dilute the effect in the morbidity meta-analysis
(Udani,14 1800 g) and the observational study
meta-analysis (Kambarini,15 1600 g and Lincetto,16
1800 g) as smaller babies have a higher risk, and
hence this bias is conservative. The exclusion of
babies <1000 g in Pattinson et al. may increase the
effect in the observational meta-analysis in the obser-
vational study meta-analysis. However, these biases
are discussed in the paper and none of these effect
sizes is being used in LiST—the analysis for morbidity
and observational trials was to examine consistency
of effect between these studies and the RCT
meta-analysis.
Misinterpretation of study
statistics
Finally we were surprised to read the section entitled
‘Misinterpretation of study statistics’, which refers to
an e-mail notice regarding the paper circulated by
others.1 This e-mail suggested that KMC could halve
all neonatal deaths, instead of halving of neonatal
deaths in stable neonates <2000 g as we clearly
stated in the paper. Such e-mails are, unfortunately,
beyond our control, and do not seem appropriate
material for a journal letter.
Conclusions
Sloan et al. agree with our statement that there is
insufficient evidence to recommend community initi-
ation of KMC.1 Although Sloan et al. state that KMC,
especially started early ‘ . . . has potential for averting
some neonatal mortality associated with prematur-
ity . . . ’, their conclusion is that there is ‘no single
adequately designed and implemented trial to demon-
strate the effect of early KMC on newborn or infant
mortality’, even for facility-based KMC. We all agree
more trials are needed, especially for community ini-
tiation, and we all agree future trials should learn
from the limitations of the ones included and
excluded here. We also all agree that there is as yet
no one ‘perfect’ trial even for facility KMC, and as
stated in our paper, all of the three RCTs in our
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meta-analysis have limitations. However, we do not
agree with Sloan et al. that policy and programme
investment in facility KMC should wait for a ‘perfect’
trial. We, and the many scientists who reviewed this
paper, believe that this review is transparent in pro-
viding a mortality effect size of KMC and in discuss-
ing the potential biases in both directions. Indeed,
many of the biases are likely to result in under-
estimation of effect for the real question for public
health relevance—namely, how much better is KMC
than no care at all.
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